Ac Immune
(NASDAQ) ACIU
Ac Immune Financials at a Glance
Market Cap
$249.35M
Revenue (TTM)
CHF 3.70M
Net Income (TTM)
-CHF 66.22M
EPS (TTM)
-$0.82
P/E Ratio
-2.99
Dividend
$0.00
Beta (Volatility)
1.14 (Average)
Dividend
$0.00
Beta (Volatility)
1.14 (Average)
Price
$2.58
Volume
17,167
Open
$2.44
Price
$2.58
Volume
17,167
Open
$2.44
Previous Close
$2.58
Daily Range
$2.44 - $2.61
52-Week Range
$1.65 - $4.00
Estimated Earnings Date
Aug 4, 2026
Dividend
$0.00
Beta (Volatility)
1.14 (Average)
Price
$2.58
Volume
17,167
Open
$2.44
Previous Close
$2.58
Daily Range
$2.44 - $2.61
52-Week Range
$1.65 - $4.00
Estimated Earnings Date
Aug 4, 2026
ACIU News
Why AC Immune Stock Surged Today
Why AC Immune SA Is Imploding
ACIU: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Ac Immune
Industry
Biotechnology
Sector
Health CareEmployees
122
CEO
Andrea Pfeifer, PhD
Website
www.acimmune.comHeadquarters
Lausanne, 1015, CH
ACIU Financials
Key Financial Metrics (TTM)
Gross Margin
100.00%
Operating Margin
-1749.00%
Net Income Margin
-1788.79%
Return on Equity
-123.98%
Return on Capital
-139.17%
Return on Assets
-48.19%
Earnings Yield
-33.44%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$249.35M
Shares Outstanding
101.77M
Volume
17.17K
Avg. Volume
272.56K
Financials (TTM)
Gross Profit
CHF 3.70M
Operating Income
-CHF 64.75M
EBITDA
-CHF 64.45M
Operating Cash Flow
-CHF 69.20M
Capital Expenditure
-CHF 900.16K
Free Cash Flow
-CHF 70.10M
Cash & ST Invst.
CHF 74.80M
Total Debt
CHF 4.30M
Ac Immune Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
CHF 1.12M
+13.0%
Gross Profit
CHF 1.12M
+13.0%
Gross Margin
100.00%
N/A
Market Cap
$249.35M
N/A
Market Cap/Employee
$1.87M
N/A
Employees
133
N/A
Net Income
-CHF 14.80M
+22.2%
EBITDA
-CHF 14.74M
+19.8%
Quarterly Fundamentals
Total Cash
CHF 74.80M
-48.6%
Total Debt
CHF 4.30M
-16.8%
Accounts Receivable
CHF 1.51M
+63.5%
Inventory
CHF 0.00
N/A
Long Term Debt
CHF 3.48M
-16.0%
Short Term Debt
CHF 825.00K
-20.1%
Return on Assets
-48.19%
N/A
Return on Invested Capital
-1.43%
N/A
Free Cash Flow
-CHF 16.55M
-383.3%
Operating Cash Flow
-CHF 16.45M
-377.2%